A. Stoye, D. Kowalczyk, T. Opatz
FULL PAPER
= 14.1 Hz, 1 H, PhCH2B), 3.02 (dd, J = 14.5, 3.8 Hz, 1 H,
ture and stirred for 15 h {TLC: Reactant: Rf = 0.54, product: Rf
= 0.35 [petroleum ether/ethyl acetate 5:3 (v/v)]}. The solvent was
removed in vacuo at the lowest possible temperature (T Յ 40 °C).
PhCH2ACHOR) 2.93 (dd,
J
=
14.5, 6.4 Hz, 1 H,
PhCH2BCHOR) ppm. 13C NMR, HSQC, HMBC (100.6 MHz,
CDCl3): δ = 171.4 (C=O), 166.4 (C-4), 135.2 (C-1Ј), 132.1 (C-1ЈЈ), Toluene (ca. 30 mL) was added and, after evaporation of the sol-
131.0 (C-2Ј,6Ј), 129.6 (C-2ЈЈ,6ЈЈ), 128.7, 128.5 (C-3Ј,5Ј, C-3ЈЈ,5ЈЈ), vent under reduced pressure, the remaining residue was dissolved in
127.8, 127.3 (C-4Ј, C-4ЈЈ), 108.8 (C-2), 75.6 (C-4), 67.3 dichloromethane (10.0 mL) and cooled to 0 °C. TESOTf (660 μL,
(CH2O2CCH2Cl), 41.8 (PhCH2), 40.4 (O=CCH2Cl), 37.6 770 mg, 2.90 mmol, 1.20 equiv.) and NEt3 (610 μL, 440 mg,
(PhCH CHOR) ppm. FTIR (ATR): ν = 3032, 1800, 1766, 1285, 4.36 mmol, 1.80 equiv.) were then added dropwise to the stirred
˜
2
1090, 957, 756, 701 cm–1. ESI-MS (pos.): m/z = 397.1 [M + Na]+.
solution of the crude alcohol 13b in dichloromethane (10 mL) at
HRMS (ESI): calcd. for C20H19ClNaO5 [M + Na]+ 397.0819; 0 °C. Stirring was continued at room temp. until TLC showed com-
found 397.0808.
plete conversion (2 h). Sometimes the addition of a second portion
of TESOTf (330 μL, 1.45 mmol, 0.60 equiv.)/triethylamine (305 μL,
2.18 mmol, 0.90 equiv.), followed by stirring for 15 h at room temp.,
was required for the reaction to run to completion. The mixture
was then cooled to 0 °C and quenched with saturated aqueous
NH4Cl solution (7 mL). After phase separation, extraction with
CH2Cl2 (2ϫ 20 mL), and washing of the combined organic extracts
with brine (75 mL), the organic phase was dried with anhydrous
Na2SO4. Evaporation of the solvent and purification by preparative
RP-HPLC on an ACE5–C18PFP column, (150 ϫ30 mm, 5 μm)
with a mixture of MeCN/H2O 77:23 (v/v) as eluent (total flow rate:
37.5 mLmin–1), afforded the TES-protected dioxolanones: the de-
sired 14b (296 mg, 30%, two steps from 12b, Rt = 12.3 min), epi-
merized 14a (118 mg, 12%, Rt = 11.0 min), and a diastereomeric
mixture of 14a/14b (28.0 mg, 3%), as well as 14c (36.0 mg, 9%,
Rt = 9.3 min), an open-chain and triethylsilyl-protected byproduct
(Scheme 4), were obtained as colorless oils.
(2S,5R)-2,5-Dibenzyl-2-{[(triethylsilyl)oxy]methyl}-1,3-dioxolan-4-
one (14a) – Cleavage with HDTC: An HDTC solution [generated
in situ (see ref.[13]), 35.6 mL, 0.375 molL–1, 13.4 mmol, 3.00 equiv.]
was added at room temperature to a stirred solution of 12a (1.67 g,
4.46 mmol) in a mixture of 2,6-lutidine (32.1 mL) and acetic acid
(10.8 mL). The reaction mixture was stirred at this temperature un-
til the starting material had been consumed (20 min) {TLC: reac-
tant: Rf = 0.54, product: Rf = 0.29 [petroleum ether/ethyl acetate
5:3 (v/v)]}, toluene (100 mL) was added, and the solvents were
evaporated in vacuo at the lowest possible temperature (T Յ 30 °C)
to afford the corresponding dioxolanone 13a, bearing a free 2-
hydroxymethyl group, as a crude product. It was used immediately,
without further purification, in the next step for best results. TE-
SOTf (1.22 mL, 5.35 mmol, 1.20 equiv.) and NEt3 (1.13 mL,
8.03 mmol, 1.80 equiv.) were added dropwise at 0 °C to a stirred
solution of the crude alcohol 13a in dichloromethane (30 mL). Stir-
ring was continued at room temp., until TLC showed complete con-
version (ca. 2 h). Sometimes addition of a second portion of TE-
SOTf (610 μL, 2.68 mmol, 0.60 equiv.)/triethylamine (560 μL,
4.02 mmol, 0.90 equiv.), followed by stirring for 15 h at room temp.,
was needed for the reaction to run to completion. The mixture was
then cooled to 0 °C and quenched with saturated aqueous NH4Cl
solution (10 mL). After phase separation, extraction with CH2Cl2
(2ϫ 30 mL), and washing of the combined organic extracts with
brine (75 mL), the organic phase was dried with sodium sulfate.
Evaporation of the solvent and purification by preparative RP-
HPLC [ACE5–C1 8 , H2 O/MeCN 23:77 (v/v), total flow:
26.2 mL min–1], afforded the TES-protected dioxolanone 14a
(860 mg, 39% over two steps from 12a) as a colorless oil.
Compound 14b: Rt = 12.3 min. Rf = 0.79 [petroleum ether/ethyl
acetate 5:1 (v/v)]. [α]2D1 = +36.4 (c = 1.0, CH3CN). 1H NMR, COSY,
NOESY (400 MHz, CD2Cl2): δ = 7.32–7.24 (m, 8 H, aryl-H), 7.18–
7.16 (m, 2 H, aryl-H), 3.94 (dd, J = 6.2, 5.1 Hz, 1 H, 5-H), 3.53 (d,
J = 11.2 Hz, 1 H, CH2AOTES), 3.26 (d, J = 11.2 Hz, 1 H,
CH2BOTES), 3.13 (d, J = 14.1 Hz, 1 H, PhCH2A), 3.01 (d, J =
14.1 Hz, 1 H, PhCH2B), 2.98–2.96 (m, 2 H, PhCH2CHOR), 0.96 (t,
J = 7.9 Hz, 9 H, SiCH2 CH3 ), 0.60 (q, J = 7.9 Hz, 6 H,
SiCH2CH3) ppm. 13C NMR, HSQC, HMBC (100.6 MHz,
CD2Cl2): δ = 172.1 (C-4), 136.2 (C-1ЈЈ), 133.7 (C-1Ј), 131.0 (C-
2ЈЈ,6ЈЈ), 129.6 (C-2Ј,6Ј), 128.27/128.28 (C-3Ј,5Ј,3ЈЈ,5ЈЈ), 127.1/126.9
(C-4Ј,4ЈЈ), 111.4 (C-2), 75.6 (C-5), 66.5 (CH2OSiEt3), 41.0 (PhCH2)
37.8 (PhCH2CHOR), 6.4 (SiCH2CH3), 4.2 (SiCH2CH3) ppm.
FTIR (ATR): ν = 3032, 2955, 2876, 1799, 1497, 1455, 1239, 1173,
˜
1080, 802, 745, 698 cm–1. ESI-MS (pos.): m/z = 435.2 [M + Na]+.
HRMS (ESI): calcd. for C24H32NaO4Si [M + Na]+ 435.1968; found
435.1964.
Compound 14a: Rt = 11.6 min Rf = 0.79 [petroleum ether/ethyl acet-
ate 5:1 (v/v)], [α]2D1 = +35.7 (c = 1.0, CH3CN). H NMR, COSY,
1
NOESY (400 MHz, CD2Cl2): δ = 7.37–7.16 (m, 10 H, aryl-H), 4.70
(dd, J = 9.0, 3.6 Hz, 1 H, 5-H), 3.75 (d, J = 11.1 Hz, 1 H, CH2
A-
(2S,5Z)-2-Benzyl-5-benzylidene-2-(hydroxymethyl)-1,3-dioxolan-4-
one [(S)-15] – Pathway A: A mixture of dioxolanone 14a (382 mg,
926 μmol) in anhydrous, degassed CCl4 (2.78 mL), N-bromosuc-
cinimide (167 mg, 926 μmol, 1.00 equiv.), and AIBN (2.03 mg,
11.4 μmol, 1.3 mol-%) was heated at reflux. After complete disap-
pearance of the starting material (1 h), the reaction mixture was
filtered through a syringe tip filter (pore size: 0.20 μm), and the
filter was then washed with CCl4 (ca. 10 mL). Evaporation of the
solvent under reduced pressure and purification by preparative NP-
HPLC [n-hexane/propan-2-ol 95:5 (v/v)] afforded (S)-15 (100 mg,
338 μmol, 36%) as a colorless oil. Rt = 28 min (column: unmodi-
OSiEt3), 3.71 (d, J = 11.1 Hz, 1 H, CH2BOSiEt3.), 2.98 (d, J =
14.3 Hz, 1 H, PhCH2A ), 2.87 (dd, J = 14.3, 3.6 Hz, 1 H,
PhCH2ACHOR), 2.85 (d, J = 14.3 Hz, 1 H, PhCH2B), 2.43 (dd,
J = 14.3, 9.0 Hz, 1 H, PhCH2BCHOR), 0.92 (t, J = 7.9 Hz, 9 H,
CH2CH3), 0.58 (q, J = 7.9 Hz, 6 H, CH2CH3) ppm. 13C NMR,
HSQC, HMBC (100.6 MHz, CD2Cl2): δ = 173.0 (C-4), 137.1 (C-
1ЈЈ), 134.0 (C-1Ј), 131.3 (C-2ЈЈ,6ЈЈ), 129.7 (C-2Ј,6Ј), 128.7, 128.5 (C-
3Ј,5Ј, C-3ЈЈ,5ЈЈ), 127.6, 127.2 (C-4Ј, C-4ЈЈ), 111.0 (C-2), 77.6 (C-5),
67.6 (CH2OSiEt3), 41.0 (PhCH2), 38.6 (PhCH2CHOR), 6.7
(SiCH CH ), 4.5 (SiCH CH ) ppm. FTIR (ATR): ν = 3032, 2955,
˜
2
3
2
3
2876, 1797, 1497, 1455, 1236, 1131, 896, 879 796, 744, 729,
fied silica, 125ϫ21.2 mm, total flow rate: 21.2 mLmin–1). [α]2D1
=
–
1
6 9 8 c m
. E S I - M S ( p o s . ) : m / z = 4 3 5 . 2
+320 (c = 0.5, CH3CN). 1H NMR, COSY, NOESY (600 MHz,
CD3CN): δ = 7.73 (mc, 2 H, 2ЈЈ,6ЈЈ-H), 7.44 (mc, 2 H, 3ЈЈ,5ЈЈ-H),
7.37 (mc, 1 H, 4ЈЈ-H), 7.32–7.29 (m, 2 H, 2Ј,6Ј-H), 7.26–7.24 (m,
[M + Na]+. HRMS (ESI): calcd. for C24H32NaO4Si [M + Na]+
435.1968; found 435.1964.
(2R,5R)-2,5-Dibenzyl-2-{[(triethylsilyl)oxy]methyl}-1,3-dioxolan-4- 3 H, 3Ј,4Ј,5Ј-H), 6.15 (s, 1 H, PhCH=COR), 3.85 (dd, J = 12.8,
one (14b) – Deprotection Procedure with Thiourea: A stirred solu-
tion of 12b (906 mg, 2.42 mmol) in DMF (5.00 mL) was treated
with thiourea (441 mg, 5.81 mmol, 2.40 equiv.) at room tempera-
6.2 Hz, 1 H, CH2OH), 3.83 (dd, J = 12.8, 6.2 Hz, 1 H CH2OH),
3.57 (t, J = 6.2 Hz, 1 H, OH), 3.30 (d, J = 14.3 Hz, 1 H PhCH2A),
3.30 (d, J = 14.3 Hz, 1 H PhCH2B) ppm. 13C NMR, HSQC,
5958
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 5952–5960